Key facts
- Salva Health’s last known valuation is $8.0M (Mar 2024).
- It has raised $3.5M; the latest was Seed Round ($3.0M) in Dec 2025.
- Notable investors include Impact Assets, Village Capital, Flybridge (New York), Epic Angels Network, Asiri — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Salva Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Salva Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Salva Health
Developer of accessible and affordable health technologies designed to focus on disease prevention and early detection, addressing healthcare gaps in underserved regions. The company's device detects healthy and unhealthy tissues as a way to identify women who may be at risk of breast cancer, enabling healthcare professionals to prioritize those at risk and provide necessary treatment.
- Sector
- Healthcare
- HQ
- Bogota, Colombia
- Founded
- 2019
- Employees
- 16
- Website
- salvahealth.co/
- Ownership
- Privately Held (backing)
Salva Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Salva Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Salva Health in its N-PORT filings yet. We sweep new filings monthly.